91 related articles for article (PubMed ID: 10790217)
21. Expression of the MAGE-1 gene in human hepatocellular carcinomas.
Chen H; Cai S; Wang Y; Zhao H; Peng J; Pang X; Zhu J; Cong X; Rui J; Leng X; Du R; Wang Y; Vaughan H; Cebon J; Burgess AW; Chen W
Chin Med J (Engl); 2000 Dec; 113(12):1112-8. PubMed ID: 11776148
[TBL] [Abstract][Full Text] [Related]
22. [Expression of MAGE-B genes in hepatocellular carcinoma].
Mou DC; Leng XS; Peng JR; Zhao L; Wang WX; Wang Y; Li T; Zhang LG; Huang L; Zhu JY
Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):40-2. PubMed ID: 15059354
[TBL] [Abstract][Full Text] [Related]
23. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between aberrant FHIT transcripts and hepatocellular carcinoma].
Yu YC; Sun FY; Li Z; Lu SY; Teng XH
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):550-1. PubMed ID: 14552718
[TBL] [Abstract][Full Text] [Related]
25. Molecular and immunohistochemical study of the inactivation of the p16 gene in primary hepatocellular carcinoma.
Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
Chin Med J (Engl); 2000 Oct; 113(10):889-93. PubMed ID: 11775834
[TBL] [Abstract][Full Text] [Related]
26. No evidence for BCL10 mutation in endometrial cancers with microsatellite instability.
Cohn D; Mutch D; Elbendary A; Rader J; Herzog T; Goodfellow P
Hum Mutat; 2001 Feb; 17(2):117-21. PubMed ID: 11180594
[TBL] [Abstract][Full Text] [Related]
27. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
[TBL] [Abstract][Full Text] [Related]
28. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY
Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222
[TBL] [Abstract][Full Text] [Related]
29. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
[TBL] [Abstract][Full Text] [Related]
30. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of MAGE-4 gene in human hepatocellular carcinoma].
Zhao H; Rui J; Cong X; Zhao Y; Wang S; Chen S; Wang Y; Wang Y; Leng X; Chen W
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):100-2. PubMed ID: 11983123
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Chen GG; Ho RL; Wong J; Lee KF; Lai PB
Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
[TBL] [Abstract][Full Text] [Related]
33. [Mutation and amplification of RIT1 gene in hepatocellular carcinoma].
Li JT; Liu W; Kuang ZH; Zhang RH; Chen HK; Feng QS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):43-6. PubMed ID: 14767908
[TBL] [Abstract][Full Text] [Related]
34. BCL10 gene mutation in lymphoma.
Du MQ; Peng H; Liu H; Hamoudi RA; Diss TC; Willis TG; Ye H; Dogan A; Wotherspoon AC; Dyer MJ; Isaacson PG
Blood; 2000 Jun; 95(12):3885-90. PubMed ID: 10845924
[TBL] [Abstract][Full Text] [Related]
35. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.
Tanaka Y; Kanai F; Tada M; Asaoka Y; Guleng B; Jazag A; Ohta M; Ikenoue T; Tateishi K; Obi S; Kawabe T; Yokosuka O; Omata M
Oncogene; 2006 May; 25(20):2950-2. PubMed ID: 16331247
[TBL] [Abstract][Full Text] [Related]
36. Absence of Bcl10 gene mutations in Ewing's sarcomas.
Park YK; Chi SG; Unni KK
Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
[TBL] [Abstract][Full Text] [Related]
37. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
[TBL] [Abstract][Full Text] [Related]
38. [The genetic polymorphism of melanoma-associated antigen 1 in Chinese normal donors and hepatoma patients].
Wang LP; Chen HS; Mei MH; Qin LL; Cong X; Fei R; Xu J; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):151-5. PubMed ID: 15059299
[TBL] [Abstract][Full Text] [Related]
39. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
Zhang J; Zheng J; Fang W
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]